HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$3.96
Day range
$3.97 - $6.65
Year range
$1.08 - $19.00
Market cap
40.28M USD
Avg Volume
654.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.38M | -23.35% |
Net income | -3.78M | -7.71% |
Net profit margin | — | — |
Earnings per share | -0.95 | 83.04% |
EBITDA | -3.80M | -7.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 321.30K | -90.96% |
Total assets | 2.06M | -64.54% |
Total liabilities | 5.10M | 60.50% |
Total equity | -3.05M | — |
Shares outstanding | 6.75M | — |
Price to book | -4.35 | — |
Return on assets | -323.03% | — |
Return on capital | 855.41% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.78M | -7.71% |
Cash from operations | -1.76M | 42.70% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 21.05K | -99.26% |
Net change in cash | -1.74M | -649.61% |
Free cash flow | -207.01K | 89.28% |
About
Founded
1999
Headquarters
Website
Employees
13
